114 results
8-K
EX-3.1
RYTM
Rhythm Pharmaceuticals Inc.
16 Apr 24
Entry into a Material Definitive Agreement
7:00am
, or any other settlement on audit that is binding on the Company. Each Holder agrees to provide, at the time it becomes a party hereto and thereinafter
8-K
EX-10.1
RYTM
Rhythm Pharmaceuticals Inc.
1 Apr 24
Rhythm Pharmaceuticals Secures $150 Million in Convertible Preferred Stock Financing
5:25pm
, to the Company’s outside auditors and the Board of Director’s audit committee (A) any material weaknesses in the design or operation of internal controls over … for the periods then ended (subject, in the case of unaudited quarterly statements, to the absence of footnote disclosures and normal year-end audit
8-K
g5wz9kmqb2 bbe4
22 Feb 24
Rhythm Pharmaceuticals Reports Fourth Quarter 2023 Financial Results and Business Update
7:01am
8-K
gmf1s2bk
8 Aug 23
Departure of Directors or Certain Officers
7:32am
8-K
EX-10.1
9brjaw
3 Aug 23
Departure of Directors or Certain Officers
5:22pm
8-K
EX-10.2
zsc8e7 zmxc2
3 Aug 23
Departure of Directors or Certain Officers
5:22pm
8-K
EX-10.4
eesznzzpzoutb
3 Aug 23
Departure of Directors or Certain Officers
5:22pm
8-K
EX-10.3
tf7xh8bazg mq96s
3 Aug 23
Departure of Directors or Certain Officers
5:22pm